Appelmelk BJ, van Die I, van Vliet SJ, Vandenbroucke-Grauls CMJE, Geijtenbeek TBH, van Kooyk Y. Cutting edge: carbohydrate profiling identifies new pathogens that interact with dendritic cell-specific ICAM-3-grabbing nonintegrin on dendritic cells. J Immunol. 2003;170:1635–9. https://doi.org/10.4049/jimmunol.170.4.1635.

Article  CAS  PubMed  Google Scholar 

Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998;392:245–52. https://doi.org/10.1038/32588.

Article  CAS  PubMed  Google Scholar 

Banerjee A, Chitnis UB, Jadhav SL, Bhawalkar JS, Chaudhury S. Hypothesis testing, type I and type II errors. Ind Psychiatry J. 2009;18:127. https://doi.org/10.4103/0972-6748.62274.

Article  PubMed  PubMed Central  Google Scholar 

Barreiro LB, Neyrolles O, Babb CL, Tailleux L, Quach H, McElreavey K, van Helden PD, Hoal EG, Gicquel B, Quintana-Murci L. Promoter variation in the DC-SIGN–encoding gene CD209 is associated with tuberculosis. PLoS Med. 2006;3:e20. https://doi.org/10.1371/journal.pmed.0030020.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ben-Ali M, Barreiro LB, Chabbou A, Haltiti R, Braham E, Neyrolles O, Dellagi K, Gicquel B, Quintana-Murci L, Barbouche M-R. Promoter and neck region length variation of DC-SIGN is not associated with susceptibility to tuberculosis in Tunisian patients. Hum Immunol. 2007;68:908–12. https://doi.org/10.1016/j.humimm.2007.09.003.

Article  CAS  PubMed  Google Scholar 

Chang K, Deng S, Lu W, Wang F, Jia S, Li F, Yu L, Chen M. Association between CD209 − 336A/G and − 871A/G polymorphisms and susceptibility of tuberculosis: a meta-analysis. PLoS ONE. 2012;7:e41519. https://doi.org/10.1371/journal.pone.0041519.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Castro KG, Ward JW, Slutsker L, Buehler JW, Jaffe HW, Berkelman RL, from National Center for Infectious Diseases Division of HIV/AIDS; and Curran JW, from Office of the Director Associate Director for HIV/AIDS. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep;1993;41:1–19

Google Scholar 

Geijtenbeek TB, den Dunnen J, Gringhuis SI. Pathogen recognition by DC-SIGN shapes adaptive immunity. Future Microbiol. 2009;4:879–90. https://doi.org/10.2217/fmb.09.51.

Article  CAS  PubMed  Google Scholar 

Geijtenbeek TBH, Kwon DS, Torensma R, van Vliet SJ, van Duijnhoven GCF, Middel J, Cornelissen ILMHA, Nottet HSLM, KewalRamani VN, Littman DR, Figdor CG, van Kooyk Y. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell. 2000;100:587–97. https://doi.org/10.1016/S0092-8674(00)80694-7.

Article  CAS  PubMed  Google Scholar 

Geijtenbeek TBH, Torensma R, van Vliet SJ, van Duijnhoven GCF, Adema GJ, van Kooyk Y, Figdor CG. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell. 2000;100:575–85. https://doi.org/10.1016/S0092-8674(00)80693-5.

Article  CAS  PubMed  Google Scholar 

Geijtenbeek TBH, van Vliet SJ, Koppel EA, Sanchez-Hernandez M, Vandenbroucke-Grauls CMJE, Appelmelk B, van Kooyk Y. Mycobacteria target DC-SIGN to suppress dendritic cell function. J Exp Med. 2003;197:7–17. https://doi.org/10.1084/jem.20021229.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gilks CF, Crowley S, Ekpini R, Gove S, Perriens J, Souteyrand Y, Sutherland D, Vitoria M, Guerma T, De Cock K. The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings. Lancet. 2006;368:505–10. https://doi.org/10.1016/S0140-6736(06)69158-7.

Article  PubMed  Google Scholar 

Gómez LM, Anaya J-M, Sierra-Filardi E, Cadena J, Corbí Á, Martín J. Analysis of DC-SIGN (CD209) functional variants in patients with tuberculosis. Hum Immunol. 2006;67:808–11. https://doi.org/10.1016/j.humimm.2006.07.003.

Article  CAS  PubMed  Google Scholar 

Green MR, Sambrook J, Sambrook J. Molecular cloning: a laboratory manual. 4th ed. Cold Spring Harbor, N.Y.: Cold Spring Harbor Laboratory Press; 2012.

Google Scholar 

Gringhuis SI, den Dunnen J, Litjens M, van het Hof B, van Kooyk Y, Geijtenbeek TBH. C-type lectin DC-SIGN modulates toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-κB. Immunity. 2007;26:605–16. https://doi.org/10.1016/j.immuni.2007.03.012.

Article  CAS  PubMed  Google Scholar 

Kettani AE, Jebbar S, Takourt B, Maaloum F, Diraa O, Farouqi B, Zerouali K, Filali KME. Co-infection VIH chez les tuberculeuxsuivis au service des maladies infectieuses du CHU Ibn Rochd–Casablanca. Pan Afr Med J. 2018. https://doi.org/10.11604/pamj.2018.30.276.13913.

Article  PubMed  PubMed Central  Google Scholar 

Koizumi Y, Kageyama S, Fujiyama Y, Miyashita M, Lwembe R, Ogino K, Shioda T, Ichimura H. RANTES −28G delays and DC-SIGN − 139C enhances AIDS progression in HIV type 1-infected Japanese hemophiliacs. AIDS Res Hum Retrovir. 2007;23:713–9. https://doi.org/10.1089/aid.2006.0225.

Article  CAS  PubMed  Google Scholar 

van Kooyk Y, Geijtenbeek TBH. DC-SIGN: escape mechanism for pathogens. Nat Rev Immunol. 2003;3:697–709. https://doi.org/10.1038/nri1182.

Article  CAS  PubMed  Google Scholar 

Lozach P-Y, Nobile C, Altmeyer R, Schwartz O. DC-SIGN : un récepteur viral à large spectre. Virologie. 2004;8:113–24.

Google Scholar 

Lugo-Villarino G, Troegeler A, Balboa L, Lastrucci C, Duval C, Mercier I, Bénard A, Capilla F, Al Saati T, Poincloux R, Kondova I, Verreck FAW, Cougoule C, Maridonneau-Parini I, del Sasiain MC, Neyrolles O. The C-type lectin receptor DC-SIGN has an anti-inflammatory role in human M(IL-4) macrophages in response to Mycobacterium tuberculosis. Front Immunol. 2018. https://doi.org/10.3389/fimmu.2018.01123.

Article  PubMed  PubMed Central  Google Scholar 

Martin MP, Lederman MM, Hutcheson HB, Goedert JJ, Nelson GW, van Kooyk Y, Detels R, Buchbinder S, Hoots K, Vlahov D, O’Brien SJ, Carrington M. Association of DC-SIGN promoter polymorphism with increased risk for parenteral, but not mucosal, acquisition of human immunodeficiency virus type 1 infection. J Virol. 2004;78:14053–6. https://doi.org/10.1128/JVI.78.24.14053-14056.2004.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mason C, Tarr A. Human lectins and their roles in viral infections. Molecules. 2015;20:2229–71. https://doi.org/10.3390/molecules20022229.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Netgen Co-infection tuberculose et VIH: enjeuxthérapeutiques. In: Revue Médicale Suisse. https://www.revmed.ch/RMS/2011/RMS-318/Co-infection-tuberculose-et-VIH-enjeux-therapeutiques. Accessed 28 Dec 2020

Ni X, Austin M, Langridge T, Bojaxhi P, Bijani P, Wang X, Duvic M. CD209+ monocyte-derived myeloid dendritic cells were increased in patients with leukemic cutaneous T-cell lymphoma undergoing extracorporeal photopheresis via the CELLEXTM system. Photodermatol Photoimmunol Photomed. 2020;36:290–8. https://doi.org/10.1111/phpp.12552.

Article  CAS  PubMed  Google Scholar 

Pugliese P, Cuzin L, Enel P, Agher R, Alfandari S, Billaud E, Druard P, Duvivier C, Perez M, Salmi D, Pradier C. NADIS 2000, development of an electronic medical record for patients infected by HIV, HBV and HCV. Presse Med. 2003;32:299–303.

CAS  PubMed  Google Scholar 

Qian Y-W, Li C, Jiang A-P, Ge S, Gu P, Fan X, Li T-S, Jin X, Wang J-H, Wang Z-L. HIV-1 gp120 glycoprotein interacting with dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN) down-regulates tight junction proteins to disrupt the blood retinal barrier and increase its permeability. J Biol Chem. 2016;291:22977–87. https://doi.org/10.1074/jbc.M116.744615.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sakuntabhai A, Turbpaiboon C, Casadémont I, Chuansumrit A, Lowhnoo T, Kajaste-Rudnitski A, Kalayanarooj SM, Tangnararatchakit K, Tangthawornchaikul N, Vasanawathana S, Chaiyaratana W, Yenchitsomanus P, Suriyaphol P, Avirutnan P, Chokephaibulkit K, Matsuda F, Yoksan S, Jacob Y, Lathrop GM, Malasit P, Desprès P, Julier C. A variant in the CD209 promoter is associated with severity of dengue disease. Nat Genet. 2005;37:507–13. https://doi.org/10.1038/ng1550.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Selvaraj P, Alagarasu K, Swaminathan S, Harishankar M, Narendran G. CD209 gene polymorphisms in south Indian HIV and HIV-TB patients. Infect Genet Evol. 2009;9:256–62. https://doi.org/10.1016/j.meegid.2008.12.003.

Article  CAS  PubMed  Google Scholar 

da Silva RC, Segat L, da Cruz HLA, Schindler HC, Montenegro LML, Crovella S, Guimarães RL. Association of CD209 and CD209L polymorphisms with tuberculosis infection in a Northeastern Brazilian population. Mol Biol Rep. 2014;41:5449–57. https://doi.org/10.1007/s11033-014-3416-y.

Article  CAS  PubMed  Google Scholar 

Tailleux L, Gicquel B, Neyrolles O. DC-SIGN, un récepteur clé du bacille de la tuberculose ? Med Sci (Paris). 2003;19:658–60. https://doi.org/10.1051/medsci/20031967658.

Article  PubMed  Google Scholar 

Tailleux L, Schwartz O, Herrmann J-L, Pivert E, Jackson M, Amara A, Legres L, Dreher D, Nicod LP, Gluckman JC, Lagrange PH, Gicquel B, Neyrolles O. DC-SIGN Is the major Mycobacterium tuberculosisreceptor on human dendritic cells. J Exp Med. 2003;197:121–7. https://doi.org/10.1084/jem.20021468.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tuberculosis (TB). https://www.who.int/news-room/fact-sheets/detail/tuberculosis. Accessed 19 Mar 2022

Vannberg FO, Chapman SJ, Khor CC, Tosh K, Floyd S, Jackson-Sillah D, Crampin A, Sichali L, Bah B, Gustafson P, Aaby P, McAdam KPWJ, Bah-Sow O, Lienhardt C, Sirugo G, Fine P, Hill AVS. CD209 genetic polymorphism and tuberculosis disease. PLoS ONE. 2008;3:e1388. https://doi.org/10.1371/journal.pone.0001388.

Article  CAS  PubMed  PubMed Central